Agility Training and Its Relations in Elderly Adults With and Without MCI
Key facts
- Who runs it
- National Taiwan University Hospital
- Where
- Taiwan1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 83 people enrolled
- Started
- 28 Sept 2022
- Ended
- 13 Mar 2025
- Type of study
- Interventional, 8 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Health education
- Multicomponent training
- Agility training
- Record updated
- 31 August 2026
Who can take part
- Age
- 20 years to 100 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 26 criteriaShow less
Who can take part
- has a score of ≥ 24 on the Mini-Mental State Examination (MMSE)
- able to walk independently for more than 30 meters without assistive aids
- able to follow orders
- older than 65 years old
- score of Mini-Mental State Examination (MMSE) ≥ 24 and score of Montreal Cognitive Assessment (MoCA) ≤ 26
- able to walk independently for more than 30 meters without assistive aids
- able to follow orders
- older than 65 years old
- score of Mini-Mental State Examination (MMSE) ≥ 24
- able to walk independently for more than 30 meters without assistive aids
- able to follow orders
Who cannot take part
- currently taking antidepressants, anti-anxiety, or other psychiatric drugs that may affect blood flow in the brain
- currently taking antidepressants, anti-anxiety, or other psychiatric drugs that may affect blood flow in the brain
- currently taking antidepressants, anti-anxiety, or other psychiatric drugs that may affect blood flow in the brain
- poorly-controlled or unstable systematic disease
- has a history of central nervous system disease
- poorly controlled or unstable systematic disease
- has a history of central nervous system disease
- has other medical conditions for which exercise is contraindicated
- poorly controlled or unstable systematic disease
- has a history of central nervous system disease
- has other medical conditions for which exercise is contraindicated
- subjects with achromatopsia; Part 2:
- subjects with achromatopsia; Part 3:
- subjects with achromatopsia
Other criteria
- Part 1:
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The following three-part proposal will focus on the effects of agility training as well as the relationship between agility ability and motor and cognitive function, and risk of falls in elderly adults with or without mild cognitive impairment (MCI).
Read full original descriptionShow less
Part I is a cross-sectional study design that will assess the level of agility in healthy young adults, healthy elderly adults, and elderly adults with MCI to determine the effect of aging and cognition decline on agility and the relations between agility, cognitive, and motor functions. Thirty participants will be screened for eligibility and recruited for each group (90 participants total). After collecting basic data, all participants will undergo cognitive and motor function tests, as well as an agility test. Cognitive function tests include tests of global cognition, working memory, mental set shifting, and selective attention. Motor function tests include tests of single and dual task walking, strength, power, balance, flexibility, and endurance. The agility test contains stop-and-go, change of direction, and spatial orientation components. Functional near-infrared spectroscopy (fNIRS) will be used to evaluate the brain activation during the agility test, cognitive tests, and single and dual task walking. Results from all tests will be used to determine the motor, cognitive, and other predictive factors associated with agility performance, and will be used in the design of the training program in Part II and III.
Part II and III are single-blinded randomized controlled trials that will explore the short and long-term effects of a multicomponent training and an agility training protocol on agility, motor, and cognitive function in elderly adults with and without MCI. Seventy-five elderly adults with MCI (Part II) and seventy-five healthy elderly (Part III) will be recruited. After screening for eligibility and collection of demographic data, participants will undergo a pretest assessment. In addition to the motor, cognitive, and agility tests used in Part I, information on history of falls, falls efficacy, and quality of life will be assessed for each participant. Brain activation will be assessed during the agility test, cognitive tests, and single and dual task walking assessments using fNIRS. Participants will be randomly allocated into one of three groups: the control group, the multicomponent training group, or the agility training group (n=25 in each group). Intervention will be executed at a frequency of 45 minutes per session, 2 times a week for 8 weeks. The control group will receive home-based health education guidelines. The multicomponent training group will engage in 3 to 4 exercises each training session comprising the influencing factors of agility, and the agility training group will engage in integrated task-specific training. A post-test will be conducted after the 8-week intervention, and 1-month, 6-month, and 12-month follow-ups will be conducted for elderly adults with MCI. The healthy elderly adults will be assessed after the intervention and at the 1-month follow-up after training.
The 8 groups in the trial
- Healthy adultsNo study treatment, for comparison
Year 1: To assess levels of agility and agility performance in relation to the motor and cognitive abilities of healthy young adults, healthy elderly, and elderly with MCI.
- Healthy elderly and mild cognitive impairment elderlyNo study treatment, for comparison
Year 1: To assess levels of agility and agility performance in relation to the motor and cognitive abilities of healthy young adults, healthy elderly, and elderly with MCI.
- Mild cognitive impairment elderly with health educationExisting treatment, for comparison
Year 2: To determine the short and long-term effects of a multicomponent training protocol and an agility training protocol on agility, motor, and cognitive function in elderly with MCI.
Treatment: Health education
- Mild cognitive impairment elderly with multicomponent trainingTreatment being tested
Year 2: To determine the short and long-term effects of a multicomponent training protocol and an agility training protocol on agility, motor, and cognitive function in elderly with MCI.
Treatment: Multicomponent training
- Mild cognitive impairment elderly with agility trainingTreatment being tested
Year 2: To determine the short and long-term effects of a multicomponent training protocol and an agility training protocol on agility, motor, and cognitive function in elderly with MCI.
Treatment: Agility training
- Healthy elderly with health educationExisting treatment, for comparison
Year 3: To determine the short and long-term effects of a multicomponent training protocol and an agility training protocol on agility ability, motor, and cognitive function in healthy elderly adults.
Treatment: Health education
- Healthy elderly with multicomponent trainingTreatment being tested
Year 3: To determine the short and long-term effects of a multicomponent training protocol and an agility training protocol on agility ability, motor, and cognitive function in healthy elderly adults.
Treatment: Multicomponent training
- Healthy elderly with agility trainingTreatment being tested
Year 3: To determine the short and long-term effects of a multicomponent training protocol and an agility training protocol on agility ability, motor, and cognitive function in healthy elderly adults.
Treatment: Agility training
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Effects of an Agility Training and Its Relation to Motor, Cognitive Performance and Fall Risk in Elderly Adults With and Without Mild Cognitive Impairment
- Record updated
- 31 August 2026